INTRODUCTION
============

*Streptococcus pneumoniae* (pneumococci) are Gram-positive human commensals but also pathogens with high virulence potential. Pneumococci are dreaded as the etiologic agent of respiratory and life-threatening invasive diseases, such as pneumonia, meningitis and septicemia. The disease burden is high in developed and developing countries and, *e.g*. one million children under the age of 5 years are killed every year (Gamez & Hammerschmidt, [@b17]; Kadioglu et al, [@b31]). Its location in the human respiratory tract forces the bacterial cell to develop mechanisms to resist the host defenses like the oxidative burst produced by the innate immune system (West et al, [@b60]).

Reactive oxygen species (ROS) are also produced during one-electron transfer reactions to O~2~ that include hydrogen peroxide (H~2~O~2~), hydroxyl radical (HO^•^) and superoxide anions (O~2~^−^). ROS are able to react with all cellular macromolecules, such as proteins, lipids, carbohydrates and nucleotides (Gutteridge & Halliwell, [@b19]; Johansson et al, [@b29]). Cysteine and methionine (Met) residues are the most susceptible targets for oxidation by ROS. The oxidation of Met residues in proteins generates methionine sulfoxides (MetSO) that can induce conformational changes leading either to activation or inactivation of proteins (Zeller & Klug, [@b67]). In eukaryotic cells, Met oxidation has been shown to inactivate calmodulin and activate calmodulin kinase (Bigelow & Squier, [@b3]; Erickson et al, [@b15]) or in *Escherichia coli* the transcription factor HypT is activated specifically by MetSO formation (Drazic et al, [@b14]). This reaction is reversible and MetSO modifications can be reduced to Met by methionine sulfoxide reductases (Msr). Depending on the stereospecific orientation two distinct classes of Msr enzymes have been described. MsrA is specific for the reduction of the S-form and MsrB reduces the R-form of MetSO (Brot et al, [@b5]; Grimaud et al, [@b18]; Sharov & Schoneich, [@b56]; Weissbach et al, [@b59]). MsrA and MsrB occur typically as separate enzymes, but in some bacteria like *S. pneumoniae*, *Neisseria gonorrhoeae* and *Haemophilus influenzae* they are translationally fused as MsrAB (Delaye et al, [@b12]; Kim et al, [@b33]; Tarrago & Gladyshev, [@b57]; Wizemann et al, [@b61]). The reduction of MetSO by Msr involves the formation of an intramolecular disulphide in MsrA and MsrB, which is reduced by thioredoxins (Trx) that transfer electrons from their CXXC active site to the MsrA and MsrB disulphides (Hoshi & Heinemann, [@b27]; Lowther et al, [@b39]; Ranaivoson et al, [@b52]). The reduction of MsrA and MsrB by Trx leads to oxidation of Trx, which is reduced by the thioredoxin reductase (TrxB) on expense of NADPH. The Trx/TrxB system together with the glutaredoxin/glutathione (GSH)/GSH reductase system maintain the cellular reducing environment (Fernandes & Holmgren, [@b16]; Paget & Buttner, [@b42]). Trx proteins also function as electron donors to regenerate peroxiredoxins and other antioxidant enzymes in their detoxification cycle (Collet & Messens, [@b7]; Das & Das, [@b11]; Hanschmann et al, [@b21]; Kang et al, [@b32]; Zander et al, [@b66]).

Pneumococci are able to produce millimolar H~2~O~2~ by the pyruvate oxidase SpxB as a chemical weapon against bacterial competitors and hence this pathogen can tolerate high H~2~O~2~ concentrations (Pericone et al, [@b44], [@b46]). By H~2~O~2~ production *S. pneumoniae* can displace *H. influenzae*, *N. meningitidis* and *Staphylococcus aureus*, which also involves the induction of resident prophages in *S. aureus* (Margolis, [@b40]; Pericone et al, [@b45]; Selva et al, [@b55]).

Despite their peroxide resistance, pneumococci lack the major peroxide scavenging enzyme catalase. However, other ROS scavenging enzymes, like the superoxide dismutase (SodA) (Yesilkaya et al, [@b65]), NADH oxidase (Auzat et al, [@b2]) and alkyl hydroperoxidase (Paterson et al, [@b43]) limit ROS mediated killing in the cytoplasm. In addition, the thiol peroxidase (TpxD) functions in H~2~O~2~ detoxification and survival under aerobic conditions and is responsible for enhanced survival of pneumococci in mice virulence assays after intranasal infections (Hajaj et al, [@b20]; Hiller et al, [@b24]; Yesilkaya et al, [@b64]). Recently, the roles of the cellular redox buffer GSH, its GshT importer and the glutathione reductase (Gor) in protection against oxidative stress and during pneumococcal colonization have been demonstrated (Potter et al, [@b48]). Such cytoplasmic antioxidant and protein reducing systems are well studied in many bacteria (Kim et al, [@b33]; Wizemann et al, [@b61]). In contrast, the extracellular compartment of Gram-positive bacteria and the periplasm of Gram-negatives are considered as an oxidizing environment where disulphide bond oxidases and isomerases, such as the DsbA/DsbB and DsbC/DsbD pathways catalyse oxidative protein folding (Cho & Collet, [@b6]; Denoncin & Collet, [@b13]). However, also periplasmic reducing redox pathways have been described in few pathogenic Gram-negative bacteria, such as in *N. gonorrhoeae* and *N. meningitidis* (Brot et al, [@b4]; Ranaivoson et al, [@b51]; Wu et al, [@b62]). In these periplasmic reducing redox pathways of Gram-negative bacteria, the membrane-bound DsbD protein provides the electrons for reduction of sulfenic acids, for cytochrome maturation and to reduce periplasmic antioxidant enzymes, such as peroxidases and Msr (Cho & Collet, [@b6]; Denoncin & Collet, [@b13]). In pneumococci, the extracellular thioredoxin-like protein TlpA was suggested to be involved in the extracellular oxidative stress resistance, but DsbD-like reducing redox pathways that are associated with TlpA were not explored (Andisi et al, [@b1]). In addition, the molecular interplay of the surface-exposed TlpA (renamed Etrx1) with its extracellular paralogue Etrx2 on oxidative stress resistance and virulence are unknown. This study discovers the unique molecular architecture of two surface-exposed thioredoxin-systems, Etrx1 and Etrx2 and their redox partners CcdA1, CcdA2 and *Sp*MsrAB2 as important pneumococcal extracellular reducing systems essential for pneumococcal pathogenesis and oxidative stress resistance. We further provide evidence that both CcdA-Etrx pathways function in *Sp*MsrAB2 reduction *in vivo*. Thus, Etrx1, Etrx2 and *Sp*MsrAB2 are attractive targets for the design of novel anti-infectives to block the initial states of pneumococcal infection.

RESULTS
=======

Identification and genetic organization of the *etrx1* and *etrx2* operons in pneumococci
-----------------------------------------------------------------------------------------

The bioinformatic analysis of pneumococcal genomes identified two genes encoding surface-exposed thioredoxin-like lipoproteins, renamed here Etrx1 and Etrx2. Production of the Etrx proteins in *S. pneumoniae* D39 and other strains was demonstrated by immunoblot analysis ([Fig 1](#fig01){ref-type="fig"}). Etrx1 consists of 188 amino acids (20.8 kDa) and shows 39.4% sequence identity with Etrx2 (Supporting Information Fig S1) that consists of 185 amino acids (20.7 kDa). The two potential redox partners encoded by the conserved pneumococcal three-gene *etrx1* operon are the methionine sulfoxide reductase AB2 (*Sp*MsrAB2) and cytochrome C-type biogenesis protein, renamed here CcdA1 ([Fig 1](#fig01){ref-type="fig"} and Supporting Information Figs S2--S5). *Sp*MsrAB2 shows 77% of sequence homology with the intracellular pneumococcal *Sp*MsrAB1 (Kim et al, [@b33]; Supporting Information Fig S6). The *etrx2* gene is located together with a second *ccdA*-like gene (renamed *ccdA2*) in a bicistronic operon, but without a second *msrAB-*like gene ([Fig 1](#fig01){ref-type="fig"}A and B and Supporting Information Figs S7 and S8). CcdA1 and CcdA2 share 58.8% sequence identity (Supporting Information Fig S9) and possess 18 and 21% sequence identity, respectively, with the transmembrane domain of the *Neisseria* periplasmic DsbD protein (Krupp et al, [@b36]; Supporting Information Fig S10).

![Molecular organization of the *etrx* operons in *Streptococcus pneumoniae* and schematic molecular model of isogenic *etrx*-mutants Source data is available for this figure in the Supporting Information.](emmm0005-1852-f1){#fig01}

Etrx1, Etrx2 and *Sp*MsrAB2 are displayed on the pneumococcal surface and are essential for resistance against oxidative stress
-------------------------------------------------------------------------------------------------------------------------------

Both Etrx proteins possess a typical lipoprotein-specific signal peptide containing a lipobox suggesting covalent binding of the putative lipoproteins to the outer leaflet of the phospholipid bilayer. The anchoring of lipoproteins is catalysed by a diacylglyceryl transferase (Lgt), which adds a diacylglyceryl residue to the thiol group of the conserved cysteine in the lipobox, while the signal peptide is cleaved after translocation and lipid-modification by the lipoprotein-specific signal peptidase Lsp. The lipid-modified cysteine residue remains at the mature lipoprotein as the new N-terminus (Kovacs-Simon et al, [@b35]). *Sp*MsrAB2 contains one transmembrane segment and is probably anchored via this segment to the pneumococcal membrane. To analyse the surface localization of the putative lipoproteins Etrx1 and Etrx2 and of the membrane anchored protein *Sp*MsrAB2, isogenic mutants D39Δ*etrx1*, D39Δ*etrx2* and D39Δ*msrAB2* were constructed by allelic replacement and verified by immunoblot analysis ([Fig 1](#fig01){ref-type="fig"}C and D). Flow cytometric analysis of wild-type and mutants demonstrated that Etrx1, Etrx2, and also *Sp*MsrAB2 are displayed on the pneumococcal surface of wild-type bacteria, while no surface association of Etrx1, Etrx2 and *Sp*MsrAB2 was found in the Δ*etrx1*, Δ*etrx2* and Δ*msrAB2* mutants, respectively ([Fig 2](#fig02){ref-type="fig"}A). Proteolytic treatment of pneumococci with trypsin and pronase E, respectively, followed by immunoblot analysis confirmed these results (Supporting Information Fig S11). Immunoblot analysis was further conducted for the cytoplasmic and surface-displayed protein fractions of the wild-type and an *lgt*-mutant that is unable to anchor lipoproteins in the membrane (Voss et al, [@b58]). This subcellular analysis indicated that Etrx1 and Etrx2 are indeed lipoproteins and surface-exposed. They are released into the medium fraction of the *lgt*-mutant because of their inefficient anchoring to the membrane ([Fig 2](#fig02){ref-type="fig"}B). *Sp*MsrAB2 is also displayed on the cell surface but has no lipid-anchor characteristic for lipoproteins and thus, is retained in the *lgt*-mutant membrane fraction ([Fig 2](#fig02){ref-type="fig"}B). However, we noticed that the *Sp*MsrAB2 antibodies cross-reacted with the intracellular MsrAB1 that was detected in the cytoplasm of pneumococci ([Figs 1](#fig01){ref-type="fig"}D and [2](#fig02){ref-type="fig"}B). Interestingly, the amount of *Sp*MsrAB2 was enhanced in the *ccdA1*- and *etrx1*-mutants, which was not caused by the strategy of the mutant construction ([Fig 1](#fig01){ref-type="fig"}C and Supporting Information Fig S12).

![Etrx proteins are displayed on the pneumococcal surface and essential for oxidative stress resistance Source data is available for this figure in the Supporting Information.](emmm0005-1852-f2){#fig02}

To test the effect of Etrx lipoproteins and *Sp*MsrAB2 on resistance against oxidative stress, D39 and its isogenic *etrx*-mutants were exposed for 30 min to 10, 15 and 20 mM H~2~O~2~ or for 90 min to 0.25, 0.5 and 0.75 mM paraquat ([Fig 2](#fig02){ref-type="fig"}C and D). The exposure to 10--20 mM H~2~O~2~ reduced the survival of the wild-type to about 50%. However, the *etrx1*/*etrx2* double mutant was more affected and showed only 20--30% survival after exposure to 10 mM H~2~O~2~, and less than 2% survival in the presence of 20 mM H~2~O~2~. The survival of the *etrx1* or *etrx2* single mutants was also decreased by H~2~O~2~, but to a lower degree as determined for the double mutant ([Fig 2](#fig02){ref-type="fig"}C). Similar to the *etrx*-mutants, the survival of the *msrAB2*-mutant was affected by H~2~O~2~. Remarkably, the *msrAB1*-mutant was much more sensitive to H~2~O~2~ compared to the *msrAB2* single or *etrx* double mutants ([Fig 2](#fig02){ref-type="fig"}C). This peroxide sensitive phenotype of the *msrAB2*-mutant is in agreement with a previous study (Andisi et al, [@b1]). The superoxide-generating compound paraquat showed a weaker effect on the survival of the *etrx* single mutants ([Fig 2](#fig02){ref-type="fig"}D). Surprisingly, the *etrx* double and *msrAB2* mutants were resistant to 0.25--0.5 mM paraquat, but the reasons are not known. The most dramatic effect on survival was determined for the *msrAB1*-mutant suggesting that *Sp*MsrAB1 is more important for paraquat resistance than *Sp*MsrAB2. These results suggest that both Etrx1 and Etrx2 can function as redox partners for *Sp*MsrAB2 since the inactivation of both Etrx proteins or *Sp*MsrAB2 renders pneumococci, to varying degrees, sensitive to extracellular peroxide stress.

Crystal structures of Etrx1 and Etrx2
-------------------------------------

The crystal structures of oxidized Etrx1 and Etrx2 have been solved in this study using the untagged-recombinant lipoproteins (Supporting Information Fig S13; details of the expression cloning and protein purification are described in the Supporting Information). Crystallographic data collection and model statistics are summarized in Table[1](#tbl1){ref-type="table"}. The Etrx1 model comprises amino acid residues from Ala53 to Leu187. Etrx1 presents a globular structure (38 × 28 × 29 Å) displaying a thioredoxin-like fold that contains seven β-strands and five α-helices ([Fig 3](#fig03){ref-type="fig"}A). Besides the canonical Trx fold, Etrx1 has two insertions (Supporting Information Fig S14). The first insertion (residues 53--72) results in β1, β2 and α1 elements, and the second insertion (residues 112--144) gives rise to an additional β-strand (β5) and α-helix (α3). The loop connecting β3 with α2 contains the CXXC motif (^84^CSIC^87^) defining the nucleophilic active site Cys84 and the resolving Cys87 ([Fig 3](#fig03){ref-type="fig"}D). These cysteine residues form a disulphide bridge reflecting the oxidized state of the protein. The structural data clearly show that only the active site Cys84 is solvent-exposed and accessible for electron transfer reactions. At the beginning of the second insertion and near the active site there is an additional loop connecting β4 with α3 (residues 112--120) that is not present in the closely related family of cytochrome maturation proteins. A search for proteins structurally related to Etrx1 performed with DALI server (Holm & Rosenstrom, [@b26]) identified the N-terminal domain of PilB protein (NterPilB) from *N. gonorrhoeae* (PDB code 2H30, *Z* score of 21.1 and rmsd of 1.5 Å for 133 Cα atoms), and *N. meningitidis* (PDB code 2FY6, *Z* score of 21.1 and rmsd of 2.1 Å for 136 Cα atoms) as the most closely related 3D structures. PilB is secreted to the periplasm and involved in the pathogen survival strategies against the oxidative burst as encountered in the host (Quinternet et al, [@b49]).

###### 

Data collection and refinement statistics

  Data collection          Etrx1                      Etrx2:Cyclofos 3™          Etrx2:HED
  ------------------------ -------------------------- -------------------------- --------------------------
  Space group              *P*4~3~2~1~2               *P*2~1~2~1~2~1~            *P*1
  *a*, *b*, *c* (Å)        62.85, 62.85, 89.60        61.46, 116.31, 116,42      32.10, 36.08, 58.64
  *α*, *β*, *γ* (°)        90, 90, 90                 90, 90, 90                 101.13, 100.26, 101.59
  *T* (K)                  100                        100                        100
  X-ray source             Synchrotron                Synchrotron                Synchrotron
  Wavelength (Å)           1.0053                     0.93340                    1.00000
  Resolution (Å)           29.87--1.48 (1.56--1.48)   32.81--1.77 (1.86--1.77)   23.89--1.22 (1.24--1.22)
  Total no. reflections    810807 (118971)            467968 (66226)             243076 (69159)
  No. unique reflections   30641(4393)                82391 (11813)              67595 (3219)
  Redundancy               26.5 (27.1)                5.7 (5.6)                  3.2 (3.2)
  Completeness (%)         99.9 (100)                 99.9 (99.4)                92.1 (89.0)
  Average *I/σ*(*I*)       24.2 (7.1)                 37.1 (4.2)                 13.3 (5.5)
  *R*~merge~               0.088 (0.51)               0.041 (0.48)               0.043 (0.16)
  Refinement statistics                                                          
  Resolution (Å)           28.11 (1.48)               32.81 (1.77)               23.87 (1.22)
  *R*~work~*/R*~free~      0.18/0.20                  0.16/0.19                  0.15/0.18
  Non-hydrogen atoms       1435                       5649                       2957
  Protein                  1173                       4990                       2531
  Ligands                  39                         236                        23
  Solvent                  223                        423                        403
  B-factor values (Å)^2^                                                         
  Protein                  17.80                      18.71                      16.88
  Ligands                  33.48                      64.53                      44.43
  Solvent                  31.39                      34.14                      28.43
  Rmsd bond length (Å)     0.058                      0.012                      0.009
  Rmsd bond angles (°)     1.373                      1.302                      1.256
  PDB code                 4HQS                       2YP6                       4HQZ

![Three-dimensional structures of pneumococcal surface-exposed thioredoxins](emmm0005-1852-f3){#fig03}

The three-dimensional structure of Etrx2 in complex with Cyclofos-3™ comprises the sequence from Ile43 to Asn185. Four molecules were found in the asymmetric unit presenting a similar structure (rmsd value of 0.184 Å for all Cα atoms) ([Fig 3](#fig03){ref-type="fig"}B). Etrx2 presents also a modified thioredoxin-like fold that is highly reminiscent of Etrx1 (rmsd value of 1.5 Å for 130 Cα atoms), where the classical thioredoxin-like motif of Etrx2 is embellished by a central αβ insertion and an N-terminal β-hairpin ([Fig 3](#fig03){ref-type="fig"}C). The CXXC motif (^81^CGPC^84^) defines the active site ([Fig 3](#fig03){ref-type="fig"}D). The main differences between Etrx1 and Etrx2 structures are the presence of eight extra residues forming a coil at the C-terminus of Etrx2, the conformation of β4--α3 loop, the disposition of α3 helix and the more extended conformation of the β7 strand in Etrx2 ([Fig 3](#fig03){ref-type="fig"}C and D). ResA, a thiol-disulfide oxidoreductase involved in cytochrome c biosynthesis in *Bacillus subtilis* and accepting electrons from CcdA, is the closest reported homologue of Etrx2 (rmsd of 1.5 Å for 132 Cα atoms and *Z* score of 20.7). The Cyclofos-3™ is located in close proximity to the Etrx2 active site. The ligand, found in the four monomers of the asymmetric unit, is stabilized in a pocket ([Fig 4](#fig04){ref-type="fig"}A) formed by the β4--α3 loop, the α4 helix, the α4--β3 loop and the CXXC region ([Fig 3](#fig03){ref-type="fig"}B). This pocket presents a strong hydrophobic character (Ala78, Trp80, Ala109, Pro110, Ile112, Ala141, Phe144, Ile149, Ile 122) *versus* the more polar character of the equivalent region in Etrx1 ([Fig 4](#fig04){ref-type="fig"}A--C). Cyclofos-3™ is stabilized by an H-bond with Gln113, by cation--π interaction of the polar face of the detergent with Trp80 and by pi--pi stacking interaction between phenyl ring of the detergent and Phe144 ([Fig 4](#fig04){ref-type="fig"}C). Attempts to obtain the reduced form of Etrx2 by co-crystallization with β-mercaptoethanol resulted in a new oxidized structure in which Etrx2 forms a complex with a 2-hydroxyethyl disulfide (HED) molecule ([Fig 4](#fig04){ref-type="fig"}D). A different conformation of the β4--α3 loop was observed coupled with the presence of the HED molecule at the hydrophobic cavity.

![Structural differences between Etrx1 and Etrx2 active sites](emmm0005-1852-f4){#fig04}

Both Etrx proteins share a conserved *cis*-proline residue (Pro156 in Etrx1 and Pro153 in Etrx2), placed in front of the catalytic cysteine residue, which is conserved in all thioredoxin-like proteins. As already mentioned above, the hydrophobic binding site, which is observed for Etrx2 but not for Etrx1, is of special interest. This hydrophobic binding site has not been observed in any extra-cytoplasmic thiol-disulfide oxidoreductases (TDORs) reported so far. Remarkably, both pockets differ in their amino acid composition and also in their conformation. Etrx2 presents a deep groove, while the Etrx1 site is filled by Tyr155 and covered by the α4--β3 loop. The electrostatic potential on the molecular surface is also quite different in both proteins. The Etrx2 binding site presents a hydrophobic character while Etrx1 presents a highly basic character in this region ([Fig 4](#fig04){ref-type="fig"}A). These differences point to a differential specificity of each Etrx protein for its redox partner.

Functional analysis of the extracellular thioredoxin proteins Etrx1 and Etrx2 of *S. pneumoniae*
------------------------------------------------------------------------------------------------

To decipher the function of Etrx1 and Etrx2 as thioredoxin proteins reducing the potential redox partner protein *Sp*MsrAB2, the redox states and potentials of purified Etrx proteins and *Sp*MsrAB2 subunits (MsrA2 and MsrB2; Supporting Information Fig S13) were determined. Different ratios of GSH and glutathione disulfide (GSSG) were used to determine the redox potentials. The reduced thiols of Etrx1, Etrx2 MsrA2 and MsrB2 were alkylated with AMS in an anaerobic nitrogen environment, causing a mass shift after separation by SDS--PAGE. The redox potentials were calculated from densitometric analysis and the results revealed redox potentials of −191 ± 6 mV for Etrx1, −282 ± 16.5 mV for Etrx2, −132.8 ± 5.9 mV for MsrA2 and −120.9 ± 0.6 mV for MsrB2 ([Fig 5](#fig05){ref-type="fig"}A). The apparent redox potential of purified MsrAB2 has also been analysed and was determined between the redox potential of the individual MsrA2 and MsrB2 domains, confirming the previous results. Thus, thermodynamically, the transfer of electrons from both Etrx proteins to the Msr subunits of *Sp*MsrAB2 would be possible. In order to elucidate whether both Etrx proteins can transfer electrons to *Sp*MsrAB2 kinetically, the NADPH-dependent methionine sulfoxide reductase activity of rMsrA2 and rMsrB2, respectively, was measured in kinetic experiments with Etrx1 or Etrx2 as electron donor. Calculation of the specific activities indicated that Etrx1 efficiently regenerates oxidized MsrA2 but not MsrB2. In contrast, Etrx2 can reduce MsrB2 but has a 3.6-fold lower activity for the reduction of MsrA2 compared to Etrx1 ([Fig 5](#fig05){ref-type="fig"}B and Table[2](#tbl2){ref-type="table"}).

![Reduction of SpMsrAB2 by thioredoxin lipoproteins Etrx1 and Etrx2 Source data is available for this figure in the Supporting Information.](emmm0005-1852-f5){#fig05}

###### 

Kinetic parameters of methionine sulfoxide reductase activity of MsrA2 or MsrB2

  Enzyme--substrate   *V*~max~        *K*~m~          Efficiency (*V*~max~/*K*~m~)
  ------------------- --------------- --------------- ------------------------------
  MsrA2 + Etrx1       59.0            26.5            2.22
  MsrA2 + Etrx2       8.2             13.3            0.61
  MsrB2 + Etrx1       (No activity)   (No activity)   (No activity)
  MsrB2 + Etrx2       17.1            21.0            0.81

The methionine sulfoxide reductase activity was measured in the presence of Etrx1 and Etrx2 protein, respectively. The reaction was performed at pH 7.4 in a mixture containing the Etrx protein, NADPH, human thioredoxin reductase and the reaction was started by the addition of MsrAB2 subunits.

AU, arbitrary units.

The redox state of *Sp*MsrAB2 was analysed *in vivo* for the *ccdA* single mutants as well as the *ccdA1/2* and *etrx1/2* double mutants using diagonal non-reducing/reducing SDS--PAGE assays followed by immunoblot analysis with anti-*Sp*MsrAB2 and anti-pneumococcal antisera ([Fig 5](#fig05){ref-type="fig"}C). This diagonal assay distinguishes intramolecular and intermolecular disulphides in proteins (Leichert & Jakob, [@b37]). Bacterial extracts of non-encapsulated pneumococci were harvested under non-stress control conditions and proteins with reduced thiol-groups were irreversibly alkylated with NEM (*N*-ethylmaleimide), while disulphide bonds within the same protein and between different proteins are maintained. In this diagonal assay pneumococcal protein extracts were separated in the first dimension by non-reducing SDS--PAGE, the lane was cut and separated horizontally by a second reducing SDS-PAGE. Proteins with no disulphides run along the diagonal, while intramolecular disulphides migrate slightly above the diagonal. The diagonal immunoblot analysis revealed several *Sp*MsrAB2 isoforms in the reduced form that were detected along the diagonal with the anti-*Sp*MsrAB2 antiserum ([Fig 5](#fig05){ref-type="fig"}C). The lower *Sp*MsrAB2 isoform probably is mixed with *Sp*MsrAB1 as shown by *msrAB1*- and *msrAB2*-mutant blots ([Fig 5](#fig05){ref-type="fig"}C; see also [Fig 1](#fig01){ref-type="fig"}D). Importantly, the oxidized intramolecular disulphide of the upper *Sp*MsrAB2 isoform accumulates strongly above the diagonal in the D39Δ*cps*Δ*ccdA1*Δ*ccdA2* and D39Δ*cps*Δ*etrx1*Δ*etrx2* mutants ([Fig 5](#fig05){ref-type="fig"}C), but is only weakly detected in the single *ccdA* mutants. The results suggest that *Sp*MsrAB2 is more oxidized in the *ccdA1/2* and *etrx1/2* double mutants compared to the single mutants. The functions of Etrx1 and Etrx2 as electron partners for *Sp*MsrAB2 were further demonstrated by growth experiments in the presence of 6 mM free MetSO as physiological Msr substrate. Growth in the presence of free MetSO was significantly impaired in the *msrAB2* single or *etrx1/2* and *ccdA1/2* double mutants compared to the *etrx* or *ccdA* single mutants (Supporting Information Fig S15). This MetSO-sensitive phenotype is indicative for the deficiency of methionine sulfoxide reductase activity in the absence of both functional CcdA-Etrx electron pathways *in vivo* (Supporting Information Fig S15).

Etrx1 and Etrx2 are required for full virulence of pneumococci in an acute pneumonia mouse infection model
----------------------------------------------------------------------------------------------------------

The acute experimental pneumonia and sepsis infection models were applied to assess the role of thioredoxin-like lipoproteins Etrx1 and Etrx2 on pneumococcal colonization and virulence in CD-1 outbred mice. In the acute pneumonia model mice (*n* = 12) were challenged intranasally with 1.0 × 10^7^ bioluminescent wild-type D39*lux* or its isogenic mutants D39*lux*Δ*etrx1*, D39*lux*Δ*etrx2* and D39*lux*Δ*etrx1*Δ*etrx2*, respectively. Mice infected with wild-type pneumococci or single *etrx* mutants showed the first weak signs of pneumococcal spread into the lungs at 30 h post-infection. In contrast, the D39*lux*Δ*etrx1*Δ*etrx2* double mutant showed earliest at 72 h post-infection a strong increase in bioluminescence in the lungs as monitored by real-time bioimaging, which could be correlated with a strong increase in bacterial load in the lungs ([Fig 6](#fig06){ref-type="fig"}). This delay of pneumococcal pneumonia and septicemia after intranasal infection suggested an attenuation of virulence for the double mutant D39*lux*Δ*etrx1*Δ*etrx2*. In contrast, the single knockout mutants D39*lux*Δ*etrx1* and D39*lux*Δ*etrx2* showed no significant differences in bioluminescent flux compared to D39*lux* and had mostly developed severe lung infections or succumbed to sepsis 72 h post-infection ([Fig 6](#fig06){ref-type="fig"}D). The results of the real-time monitoring correlated with the survival rates of mice. The intranasal infection with the double mutant D39*lux*Δ*etrx1*Δ*etrx2* prolonged significantly the survival time of mice (*p* \< 0.0001), whereas survival of mice infected with the Etrx1- or Etrx2-deficient single mutants was not significantly altered compared to the wild-type infected mice ([Fig 6](#fig06){ref-type="fig"}A). Similar to the H~2~O~2~ resistance only the *etrx* double mutant is affected in virulence during *in vivo* infection, while in the study of Andisi et al the attenuation of the mutant is due to the deficiency of Etrx1 (TlpA) and *Sp*MsrAB (Andisi et al, [@b1]). To investigate whether the deficiency of *Sp*MsrAB2 results in a phenotype similar to the double mutant D39*lux*Δ*etrx1*Δ*etrx2*, mice were also infected intranasally with the *msrAB*-mutants. Indeed, the results revealed significant attenuation of the *msrAB2*-mutant (*p* \< 0.0001) compared to the wild-type D39*lux* ([Fig 6](#fig06){ref-type="fig"}B, E and F). Importantly, the *etrx*-mutants and the *msrAB2*-mutant showed no growth defects under *in vitro* conditions (Supporting Information Fig S16). In contrast, the deficiency of *Sp*MsrAB1 impaired growth in a chemically defined medium (Supporting Information Fig S16) and pneumococcal virulence was also significantly reduced ([Fig 6](#fig06){ref-type="fig"}B) as has been shown previously (Wizemann et al, [@b61]). The real-time monitoring correlates with the survival rates of the mice ([Fig 6](#fig06){ref-type="fig"}E and F) and the lack of *Sp*MsrAB1 and *Sp*MsrAB2 had no additive effect. Furthermore, CD-1 mice (*n* = 9) were infected with a lower infection dose (1 × 10^6^) to explore the effect of Etrx proteins or *Sp*MsrAB2 on nasopharyngeal colonization in the carriage model. Pneumococci were recovered after 1, 3 and 5 days from the nasopharynx and the lung by a bronchioalveolar lavage. These results showed at all time points a significant reduction of nasopharyngeal carriage for the double mutant D39*lux*Δ*etrx1*Δ*etrx2* compared to the wild-type (Supporting Information Fig S17). The other *etrx*- or *msrAB2*-mutants did not significantly differ in nasopharyngeal carriage from the isogenic wild-type (Supporting Information Fig S17). However, the *msrAB2*-mutant showed immediately at 24 h post-infection a significantly reduced number of CFU in the lung (Supporting Information Fig S17B).

![Impact of the Etrx proteins on pneumococcal virulence in mice](emmm0005-1852-f6){#fig06}

To analyse the impact of the Etrx and *Sp*MsrAB2 proteins on pneumococcal survival during sepsis, mice were infected via the intraperitoneal route. The survival rates of mice (*n* = 12) were similar for groups infected with wild-type or single *etrx* mutants, although there was a moderate but not significant attenuation for the double mutant D39*lux*Δ*etrx1*Δ*etrx2* ([Fig 6](#fig06){ref-type="fig"}G). Similarly, the *msrAB2*-mutant showed no significant attenuation during invasive disease ([Fig 6](#fig06){ref-type="fig"}H).

Taken together, these *in vivo* infection experiments suggest that loss of one of the Etrx lipoproteins does not affect virulence. In contrast, loss of function of either surface-exposed Etrx lipoproteins or the *Sp*MsrAB2 protein does significantly reduce virulence and spread of pneumococci from the nasopharynx into the lungs and blood.

Pneumococcal resistance against killing phagocytosis relies on Etrx and *Sp*MsrAB2
----------------------------------------------------------------------------------

To investigate the role of the Etrx and *Sp*MsrAB2 proteins on uptake by professional phagocytes and to allow significant phagocytosis non-encapsulated pneumococci were incubated with macrophages. The results showed significantly higher numbers of internalized and recovered D39Δ*cps*Δ*etrx1*Δ*etrx2* pneumococci deficient in both Etrx proteins compared to the isogenic D39Δ*cps* and individual *etrx*-mutants ([Fig 7](#fig07){ref-type="fig"}A). The number of recovered pneumococci was also significantly increased for the *msrAB2*-mutant ([Fig 7](#fig07){ref-type="fig"}A). The increased number of phagocytosed *etrx* double mutants or *msrAB2*-mutants was also confirmed by immunofluorescence microscopy ([Fig 7](#fig07){ref-type="fig"}B). Remarkably, the lack of Etrx1 in D39Δ*cps* also accelerated phagocytosis ([Fig 7](#fig07){ref-type="fig"}A). In addition, the intracellular fate of wild-type and *etrx*-mutants was assessed. Regarding the intracellular survival, all strains showed a time-dependent decrease in the number of recovered and viable pneumococci. However, the relative decline of recovered D39Δ*cps*Δ*etrx1*Δ*etrx2* mutants did not show significant differences compared to the non-encapsulated *S. pneumoniae* D39Δ*cps*. Similar to the non-encapsulated pneumococci, phagocytosis of the encapsulated strains showed a higher number of phagocytosed and recovered mutants deficient in both Etrx proteins. These data suggest that the total loss of Etrx lipoprotein or *Sp*MsrAB2 activity accelerates phagocytosis and hence, killing of pneumococci.

![Influence of extracellular thioredoxin lipoproteins and MsrAB2 deficiency on uptake of *S. pneumoniae* D39Δ*cps* by macrophages](emmm0005-1852-f7){#fig07}

DISCUSSION
==========

Thioredoxin lipoproteins are required for resistance to extracellular oxidative stress
--------------------------------------------------------------------------------------

In this study, we performed a comprehensive functional and structural analysis of the extracellular oxidative stress resistance system of *S. pneumoniae* mediated by two CcdA-Etrx pathways and their redox partner *Sp*MsrAB2. Our results demonstrated that single *etrx*-mutants expressing *Sp*MsrAB2 showed lower susceptibility to killing by H~2~O~2~, compared to the *etrx* double mutant that had a similar peroxide sensitive phenotype like the *Sp*MsrAB2 mutant. Thus, only the deficiency of both Etrx1 and Etrx2 proteins or *Sp*MsrAB2 significantly accelerated pneumococcal killing by H~2~O~2~ and diminished growth in the presence of MetSO, respectively. Similarly, only the deficiency of both, Etrx1 and Etrx2, or their electron acceptor *Sp*MsrAB2 attenuates significantly pneumococcal virulence in the acute pneumonia model but not in the sepsis model. The importance of the Etrx proteins and *Sp*MsrAB2 for virulence functions is supported by our phagocytosis assays, which showed that only the uptake of the *etrx* double or *msrAB2* mutant is massively enhanced, whereas only a minor effect was observed for the single *etrx*-mutants. These data suggest that the Etrx proteins can functionally replace each other, which ensures proper function of surface-exposed pneumococcal proteins. The determination of the redox potentials for the Etrx and *Sp*MsrAB2 proteins together with our structural and kinetic data further demonstrate that *Sp*MsrAB2 can be reduced by both Etrx proteins. Interestingly, Etrx1 seems to reduce preferentially the MsrA2 subunit of *Sp*MsrAB2 while Etrx2 is able to reduce both MsrA2 and MsrB2 domains *in vitro* ([Fig 5](#fig05){ref-type="fig"}). Importantly, diagonal non-reducing/reducing SDS--PAGE analysis combined with *Sp*MsrAB2 specific immunoblots further verified the *in vivo* accumulation of oxidized *Sp*MsrAB2 protein especially in the *ccdA1/2* and *etrx1/2* double mutants. This indicates that both thioredoxin systems are required for efficient regeneration of *Sp*MsrAB2. Interestingly, we detected strong growth sensitivities of the *etrx1/2* double mutant in the presence of H~2~O~2~ and free MetSO as physiological MsrAB2 substrate. Hence, we postulate that both extracellular CcdA-Etrx-*Sp*MsrAB2 electron pathways are involved in reduction of oxidized Met residues present in surface-exposed virulence proteins or as free MetSO on the bacterial surface that has to be further explored in future studies.

Structural determinants of Etrx1 and Etrx2 proteins and evidence for two CcdA-Etrx-*Sp*MsrAB2 pathways
------------------------------------------------------------------------------------------------------

Thiol-disulfide oxidoreductases (TDORs) comprise a large superfamily of proteins that are present in all kingdoms of life where they control the redox state of Cys containing proteins. Cytoplasmic TDORs like the thioredoxin system are usually involved in maintaining protein cysteines in a reduced state (Fernandes & Holmgren, [@b16]). In contrast, periplasmic TDORs of Gram-negative bacteria like the Dsb family proteins or extracellular TDORs of Gram-positive bacteria catalyse disulphide bond formation or isomerization in the oxidizing periplasm or extracellular space (Cho & Collet, [@b6]; Denoncin & Collet, [@b13]). These extra-cytoplasmic or periplasmic TDORs are involved in a wide range of processes, including cytochrome maturation, *e.g. B. subtilis* ResA (Lewin et al, [@b38]), cell motility, *e.g. E. coli* DsbB (Dailey & Berg, [@b10]), natural competence development, *e.g. B. subtilis* BdbD (Meima et al, [@b41]), toxin biosynthesis, *e.g. E. coli* DsbA (Yamanaka et al, [@b63]) and synthesis of the endospore peptidoglycan cortex protective layer, *e.g. B. subtilis* StoA (Crow et al, [@b9]). Periplasmic reducing systems are present in this oxidizing compartment of Gram-negative bacteria to reduce sulfenic acids in the periplasm (*e.g*. DsbDG) or to deliver electrons for MetSO reduction (*e.g*. PilB) (Cho & Collet, [@b6]). Both Etrx1 and Etrx2 share sequence homology (30.48 and 21.83%, respectively) with the C-terminal periplasmic domain of DsbD. CcdA1 and CcdA2 are homolog to the membrane-embedded domain of DsbD (Supporting Information Fig S10). Hence, we postulate that the CcdA-Etrx-MsrAB2 pathways also function in the extracellular compartment of the Gram-positive pneumococci in MetSO reduction.

According to the accepted catalytic mechanism of thioredoxin-like proteins (Crow et al, [@b8]), Etrx1/Etrx2 would bind their redox partner *Sp*MsrAB2 by means of a hydrophobic surface and subsequently perform a nucleophilic attack on the target disulphide bond via the N-terminal nucleophilic thiolate of the CXXC motif (Cys84 in Etrx1, Cys81 in Etrx2). This process would lead to the formation of a mixed intermolecular disulphide between Etrx and its redox partner proteins, which is resolved by the second C-terminal resolving Cys residue (Cys87 in Etrx1, Cys84 in Etrx2). The N-terminal active-site Cys residue is present in the reactive thiolate anion form, which is stabilized by an interaction with the dipole of helix α2. In several thiol-disulphide oxidoreductases this interaction reduces the p*K*~*a*~ of the nucleophilic active-site Cys by at least two pH units (Roos et al, [@b54]).

In the CXXC motif of both Etrx proteins, only the active-site Cys is solvent-exposed and accessible to the redox partner (Cys84 in Etrx1 and Cys81 in Etrx2). Many thioredoxin-like proteins share also a proline residue within the CXXC motif. This proline residue is also present in the CXXC motif of Etrx2 ([Fig 3](#fig03){ref-type="fig"}D), but not in Etrx1. The presence of proline residues at the cap of the active site helix has been reported to have important consequences for the distribution of the electrostatic field near the cysteines as proline does not possess a standard peptide group (Crow et al, [@b9]). The absence of proline in Etrx1 would affect the macrodipole arising from α2 helix that is often invoked as primary cause of the lowered p*K*~*a*~ values associated with the active-site cysteine residue of the CXXC motif in most TDORs (Kortemme & Creighton, [@b34]). Furthermore, the limited conformational freedom of proline (in comparison with other residues) has been reported to be an important factor in maintaining rigidity of the CXXC motif and relevant for the structural changes from the reduced to its oxidized forms. Etrx1, representing one of the rare cases without proline in the CXXC motif, is therefore expected to have more structural variations between reduced and oxidized forms than Etrx2. Another relevant difference between both Etrx proteins and other extra-cytoplasmic TDORs concern a glutamate residue that is placed three positions after the C-terminal cysteine residue of the CXXC motif. Substitution of this glutamate has been shown to have a significant effect on the active site properties of ResA and StoA of *B. subtilis* (Crow et al, [@b9]; Hodson et al, [@b25]; Lewin et al, [@b38]). Etrx1 and Etrx2 do not have a glutamate at this position, but possess instead a serine residue (Ser90 in Etrx1 and Ser87 in Etrx2; Supporting Information Fig S18).

Etrx2 has an unprecedented hydrophobic cavity close to the active site. The presence of a hydrophobic patch near the active site has been associated with substrate recognition in other TDORs (Crow et al, [@b9]). In the structure of the oxidized forms of Etrx2, a detergent molecule (Cyclofos-3™) or a HED molecule is bound to this hydrophobic pocket, very likely mimicking the redox partner interaction. Etrx1 lacks this cavity and this region shows differences in both the nature of the amino acids and in the conformation of the β4--α3 loop ([Fig 3](#fig03){ref-type="fig"}). In agreement with these results, soaking experiments with Etrx1 crystals did not yield a complex with Cyclofos-3™ even at high concentrations of the detergent.

In conclusion, some of the structural determinants of the CXXC motif observed in other extra-cytoplasmic thioredoxins, such as the presence of proline or glutamate residues are not observed in pneumococcal Etrx proteins (except for the proline in Etrx1). Despite strong similarities in the overall fold of both, Etrx1 and Etrx2, relevant differences are observed between their active sites (presence of hydrophobic cavity in Etrx2, different electrostatic potential, different CXXC motifs). These differences provide a structural basis for the specific interaction of Etrx with the MsrA or the MsrB domains of the *Sp*MsrAB2 redox partner observed in the redox potential determination and kinetics.

Model for the two CcdA-Etrx-*Sp*MsrAB2 electron pathways
--------------------------------------------------------

The mechanism for the protection against oxidative stress via both CcdA-Etrx-*Sp*MsrAB2 electron pathways is modeled in [Fig 8](#fig08){ref-type="fig"} and Supplementary Information Movie 1. The pneumococcal cell wall is an oxidizing environment in which the sulphur-containing amino acids Met and cysteine are highly susceptible to oxidation by endogenously produced peroxide. Electrons are transported from the cytoplasmic NADPH pool to the cell wall to keep pneumococcal surface proteins in a reduced state. The first proteins of this extracellular electron transport system are the integral membrane proteins CcdA1 and CcdA2. Electrons from the cytoplasmic Trx are shuttled between CcdA1 and CcdA2 to Etrx1 and Etrx2, respectively, similarly to that observed between the transmembrane and the periplasmic domains of DsbD. Surface-exposed Etrx1 and Etrx2 deliver electrons to the *Sp*MsrAB2 protein for the reduction of MsrA2 (by Etrx1 or Etrx2) and MsrB2 (by Etrx2) domains ([Fig 8](#fig08){ref-type="fig"}). Oxidation of Met results in a mixture of the two diastereomers methionine-*S*-sulfoxide and methionine-*R*-sulfoxide, which are reduced by MsrA and MsrB, respectively. Besides the catalytic domains, *Sp*MsrAB2 also carries a transmembrane segment that anchors the protein to the membrane. It has also a long and flexible coiled coil region allowing the enzyme to reach damaged virulence proteins and to reduce MetSO ([Fig 8](#fig08){ref-type="fig"} and Supporting Information movie). Thioredoxin-like lipoproteins Etrx1/Etrx2 are critical in the turnover of the system by reducing the methionine sulfoxide reductase *Sp*MsrAB2. Since this seems to be the sole extracellular thioredoxin system of pneumococci, the lack of functional Etrx proteins or *Sp*MsrAB2 protein has direct consequences to resist oxidative stress and host immune defense mechanisms. In this sense, the pneumococcal surface-exposed thioredoxin systems reported here provide an important framework for the development of new antibacterial therapies.

![Proposed mechanism of oxidative stress defense mediated by the CcdA1-Etrx1 and CcdA2-Etrx2 electron pathways and their redox partner *Sp*MsrAB2 on the pneumococcal surface Electrons provided from NADPH by the cytoplasmic TrxB (SPD_1287) are transferred to the cytoplasmic TrxA (SPD_1567) and shuttled between the integral membrane protein CcdA1 (SPD_0571) to the surface-exposed thioredoxin-like Etrx1 (SPD_0572), and between the integral membrane protein CcdA2 (SPD_0885) to surface-exposed thioredoxin-like Etrx2 (SPD_0886) following the same mechanism. Both thioredoxin-like proteins provide reducing equivalents to *Sp*MsrAB2 (SPD_0573) for the reduction of the MsrA (by Etrx1 or Etrx2) and MsrB (by Etrx2) domains. *Sp*MsrAB2 remains anchored to the membrane and presents a long and flexible coiled coil region allowing *Sp*MsrAB2 to reach and repair ROS damaged surface proteins. Catalytic cysteine residues in Etrx1, Etrx2 and *Sp*MsrAB2 are represented as green spheres. Experimentally determined redox potentials for each protein are labelled. White arrows indicate presumed interactions and grey arrows indicate those demonstrated experimentally. All accession numbers refer to the *S. pneumoniae* D39 annotation.](emmm0005-1852-f8){#fig08}

MATERIALS AND METHODS
=====================

Bacterial strains, culture conditions and transformation techniques
-------------------------------------------------------------------

*E. coli* strains and *S. pneumoniae* genotypes and strains used in this study are listed in Supporting Information Table S1. *E. coli* and *S. pneumoniae* strains were cultured and transformed as described recently (Jensch et al, [@b28]).

Primers, construction of pneumococcal mutants and protein purification
----------------------------------------------------------------------

Primers that were used in this study and plasmids used for the mutagenesis and recombinant protein expression are listed in Supporting Information Table S2. For the generation of the pneumococcal mutants in D39*lux* (Jensch et al, [@b28]) and D39Δ*cps* the insertion--deletion mutagenesis strategy was used as described (Rennemeier et al, [@b53]). Mutagenesis, expression cloning and protein purification of His~6~-tagged proteins are described in detail in the Supporting Information.

Pneumococcal survival under oxidative conditions
------------------------------------------------

The survival experiments under oxidative condition with hydrogen peroxide (H~2~O~2~), paraquat (stimulating superoxide production in cells; kindly provided by A. Littmann, Julius Kühn Institute (JKI), Braunschweig, Germany) or MetSO (Sigma--Aldrich, Taufkirchen, Germany) were conducted as described previously (Johnston et al, [@b30]). Briefly, wild-type pneumococci and Etrx-deficient mutants were cultured in THY broth at 37°C to mid-log phase and treated for 30 min with 10, 15 or 20 mM H~2~O~2~ and 90 min with 0.25, 0.5 or 0.75 mM paraquat, respectively. Untreated pneumococci were used as a control. To determine the percentage of survival, serial dilutions were plated onto blood agar plates and CFU were counted after overnight incubation at 37°C and 5% CO~2~. In control experiments catalase (5000 U/ml) was added simultaneously with H~2~O~2~ to the bacterial cultures.

Protein crystallization
-----------------------

Etrx1 crystals were obtained with 30% v/v PEG 4000; 0.1 M tris pH 8.5; 0.2 M MgCl~2~ 18°C. Etrx2:Cyclofos 3™ complex crystal was obtained with 3.4 M sodium malonate pH 6.0 18°C, while the Etrx2:HED Complex crystal was obtained in 30% PEG 1500 supplemented with 14 mM β-mercaptoethanol. Details in Supporting Information.

Data collection, phasing and model refinement
---------------------------------------------

Native data sets of Etrx1 and Etrx2: Cyclofos-3™ crystals were collected on ESRF ID14-4 beamline in Grenoble, France. Native data set of Etrx2:HED crystal was collected on SLS PXIII beamline in Villigen, Switzerland (Table[1](#tbl1){ref-type="table"}). Details in Supporting Information.

*Sp*MsrAB2 homology model
-------------------------

The 3D model for the catalytic domains of pneumococcal *Sp*MsrAB2 (residues 60--312) was obtained by comparative homology via modeler and energy minimization.

Ethics statement
----------------

Animal experiments were performed in strict accordance with the German regulations of the Society for Laboratory Animal Science (GV-SOLAS) and the European Health Law of the Federation of Laboratory Animal Science Associations (FELASA). All experiments were approved by the ethical board and Landesamt für Landwirtschaft, Lebensmittelsicherheit und Fischerei Mecklenburg-Vorpommern (LALLFV MV), Rostock in Germany (permit no. 7221.3-1.1-006/09 and 7221.3-1.1-019/11).

Mouse models of infection and bioluminescent optical imaging
------------------------------------------------------------

Eight weeks old female outbred CD1 mice (Charles River, Sulzfeld, Germany) were infected intranasally or intraperitoneally with bioluminescent pneumococci as described recently (Hartel et al, [@b22]; Jensch et al, [@b28]). Briefly, pneumococci were cultured to *A*~600~ = 0.35 in THY supplemented with 10% foetal bovine serum and the infection dose was adjusted to 1.0 × 10^7^ CFU in 25 µl for the intranasal route (*n* = 12) and 5 × 10^3^ CFU in 100 µl for the intraperitoneal route (*n* = 12). Before intranasal infection, mice were anaesthetized by intraperitoneal injection of ketamine (Ketanest S; Pfizer Pharma, Karslruhe, Germany) and xylazine (Rompun®; Provet AG, Lyssach, Germany). Once anesthetized the animals were scuffed, with the nose held upright, and the bacterial suspension of 25 µl was administered intranasally by adding a series of small droplets into the nostrils for the mice to involuntarily inhale. The infection dose was confirmed by determination of the CFU after plating serial dilutions of the infection dose on blood agar plates. Bioluminescent optical imaging using the IVIS® Spectrum Imaging System (Caliper Life Sciences, Hopkinton, US) allowed monitoring of pneumococcal dissemination after intranasal infection (Hartel et al, [@b22]; Jensch et al, [@b28]). At pre-chosen time intervals post-infection mice were imaged for 1 min to monitor dissemination of pneumococci into the lungs. A time series of the images was generated and the bioluminescent intensity (BLI) was determined by quantification of the total photon emission using the LivingImage® 4.1 software package (Caliper Life Sciences).

Phagocytosis experiments
------------------------

To determine the rate of phagocytosed wild-type and mutant pneumococci and their intracellular survival in macrophages, phagocytosis experiments with J774A.1 murine macrophages (DSMZ, Braunschweig, Germany) were carried out as described (Hartel et al, [@b22]; Jensch et al, [@b28]).

Statistical analysis
--------------------

All data are reported as mean ± SD unless otherwise noted. Results were statistically analysed using the unpaired two-tailed Student\'s test. Kaplan--Meier survival curves were compared by the log rank test. *p* Values for bioluminescence measurements were calculated using the unpaired, one-tailed *t*-test for differences between groups, while differences of one group between days were analysed by the paired *t*-test. Statistical significance was confirmed by ANOVA analysis with Bonferroni\'s multiple comparison *post hoc* test. A *p*-value \<0.05 was considered to be statistically significant.

For more detailed materials and methods see the Supporting Information.

Accession numbers
-----------------

Sequence data for the *etrx* genes 1 and 2 of D39 or TIGR4 are deposited in the EMBL/GenBank databases under accessions numbers ABJ55360 and ABJ55355 or AAK74804 and AAK75117. Sequence data for the *ccdA1* and *ccdA2* of D39 or TIGR4 are deposited in the EMBL/GenBank databases under accession numbers ABJ54003 and ABJ54567 or AAK74803 and AAK75116. Sequence data for the *msrAB2* gene of D39 or TIGR4 are available from the EMBL/GenBank databases under accessions numbers ABJ53896 or AAK74805. The atomic coordinates and structure factors for Etrx1, Etrx2:Cyclofos-3™ complex and Etrx2:HED complex (codes 4HQS, 2YP6 and 4HQZ, respectively) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, US (<http://www.rcsb.org/>).

The paper explained
-------------------

**PROBLEM**

The respiratory pathogen *Streptococcus pneumoniae* (the pneumococcus) is a serious pathogen causing life-threatening community-acquired pneumonia and invasive diseases. The high morbidity and mortality caused by pneumococcal diseases (more than 1.5 million every year, particularly in infants, elderly and immunocompromised patients), is exacerbated by the increasing prevalence of antibiotic-resistant strains and the suboptimal efficacy of available vaccines. Pneumococci have evolved efficient mechanisms to resist protein damage under oxidative stress conditions and to displace other bacteria in the nasopharynx. While oxidative stress-resistance mechanisms in the cytoplasm are well studied, the extracellular mechanism required to resist attack from the host is less investigated.

**RESULTS:**

We have identified a two-operon system responsible for the extracellular oxidative stress resistance. This system is composed of two integral membrane proteins (CcdA1 and CcdA2), two thioredoxin-like lipoproteins (Etrx1 and Etrx2) and a single methionine sulfoxide reductase (*Sp*MsrAB2). We have solved the crystal structures of both Etrx proteins and analysed the functions of both Etrx and *Sp*MsrAB2 proteins on oxidative stress resistance and virulence. We further observed in phagocytosis experiments with macrophages that both thioredoxin lipoproteins and *Sp*MsrAB2 play a crucial role in pneumococcal pathogenesis. We can finally conclude that both Etrx proteins function as electron donors for the *Sp*MsrAB2 redox partner and are therefore crucial for the extracellular reducing redox pathways of pneumococci.

**IMPACT:**

The data highlight the crucial role of thioredoxin lipoproteins Etrx1 and Etrx2 and *Sp*MsrAB2 for virulence and the redox-reactions of the extracellular oxidative stress resistance mechanism of pneumococci. Suppression of that system severely reduces pneumococcal virulence and lethality. In this sense, the combined effect of antibiotics with new ligands blocking this crucial pneumococcal system could be intended. Therefore, our data provide a new framework for the development of novel bactericidals against this important human pathogen.
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